DoW Melanoma Research Program Focused Program Award – Rare Melanomas

DOD-AMRAA HT942526MRPFPARM
Posted: May 21, 2026 12:00:00 AM EDT
Closes: 10/14/2026

Funding Information

Estimated Total Funding
$5,600,000
Expected Number of Awards
2

Description

Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.
Distinctive Features:
·          *Updated for FY26* Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact.
·        This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1.

                   Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).

·        After submitting the required pre-application, investigators must receive an invitation to submit a full application.

                   Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project.

·        Clinical trials are allowed.

Synopsis

Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.


Distinctive Features:


·          *Updated for FY26* Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact.


·        This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1.



  •                    Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).


·        After submitting the required pre-application, investigators must receive an invitation to submit a full application.



  •                    Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project.


·        Clinical trials are allowed.

Eligibility

Eligible Applicants:
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Funding Activity Categories

Science and Technology and other Research and Development

CFDA Numbers

  • 12.420 - Military Medical Research and Development

Contact Information

Agency: Jamie Shortall Grant Officer
Contact: Jamie Shortall Grant Officer
Phone: 301-619-2393
eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org

Additional Information

Document Type: synopsis
Opportunity Category: Discretionary
Version: 1
Last Updated: May 21, 2026 12:43:23 PM EDT

Related Opportunities